Calcium-channel blockers decrease clopidogrel-mediated platelet inhibition.
about
Antiplatelet resistance in strokeFrequency of heparin/platelet factor 4-dependent platelet antibodies in patients undergoing angioplasty and stenting for cardiovascular disease and their role for on-clopidogrel platelet reactivity.Combined influence of proton-pump inhibitors, calcium-channel blockers and CYP2C19*2 on on-treatment platelet reactivity and on the occurrence of atherothrombotic events after percutaneous coronary intervention.Cytochrome P450 2C19 polymorphism is associated with reduced clopidogrel response in cerebrovascular disease.A comparison of two brands of clopidogrel in patients with drug-eluting stent implantation.Almanac 2011: stable coronary artery disease. The national society journals present selected research that has driven recent advances in clinical cardiology.Clopidogrel and the possibility of drug-drug interaction in primary health care.Antiplatelet effect of clopidogrel can be reduced by calcium-channel blockers.Clopidogrel in acute coronary syndrome: implications of recent study findings.The future of platelet function testing to guide therapy in clopidogrel low and enhanced responders.Managing adverse effects and drug-drug interactions of antiplatelet agents.Genetic and non-genetic factors affecting the response to clopidogrel therapy.Genetic polymorphisms and drug interactions leading to clopidogrel resistance: why the Asian population requires special attention.Monitoring aspirin and clopidogrel response: testing controversies and recommendations.Antiplatelet treatment in essential hypertension: where do we stand?Clinical determinants of clopidogrel responsiveness in a heterogeneous cohort of Puerto Rican Hispanics.The Antiplatelet Effect of Clopidogrel Decreases With Patient Age.Predictors of high on-aspirin platelet reactivity in elderly patients with coronary artery disease.Disaggregation Following Agonist-Induced Platelet Activation in Patients on Dual Antiplatelet Therapy.The influence of CYP 2C19*2 polymorphism on platelet function testing during single antiplatelet treatment with clopidogrelVariability of platelet response to clopidogrel is not related to adverse cardiovascular events in patients with stable coronary artery disease undergoing percutaneous coronary intervention.Calcium-Channel Blockers Attenuate the Antiplatelet Effect of Clopidogrel.Concomitant use of calcium channel blockers with dual antiplatelet therapy and re-hospitalization for acute coronary syndrome.Use of clopidogrel and calcium channel blockers and risk of major adverse cardiovascular events
P2860
Q22305927-45FADFDD-ACF2-4E15-876D-07133B73356FQ33399119-85CB0E69-CA3A-4508-B6BD-396038C0BC82Q33997642-94360F31-5EB2-4BEE-902C-9B974886209BQ35176276-31E2C9CD-AB98-422A-AED0-EF96E08F47F5Q36131394-91611E85-CE7F-4950-BB12-66566ECD9489Q36787252-40D077FF-EF7F-4646-9C3F-484D48861F61Q37134415-09497973-29CA-44E0-9EB5-0121FE1A3023Q37708274-5D3A9A36-D4C1-4200-B4B8-FC7C8C2897A5Q37786639-5DD57403-CA7B-4D35-A3D8-34FF960BA501Q37923969-15FA32DE-EC2B-4F00-BB3A-5BE4666EA827Q37930967-9849310F-6F41-454B-9FD2-8775085975D3Q37991382-5434D1D2-72EC-4EC1-B809-A4CE8A3B0810Q38056525-BC0E191A-FB70-43B2-A9BB-E3A25D9534B9Q38099235-D5BDCF9B-6718-460B-BD73-A2F27811E935Q38384163-13F9578C-A255-4A0A-82A8-0E9CC1E00401Q38694265-93BC1E4D-70F9-47E8-BE99-E2E14CFC9ABEQ40009280-1D1E14B7-B19E-4189-A392-591216683AF2Q41405409-CA496141-2EAF-4779-8043-E1BA053E8575Q41620557-EDD628AD-759F-4411-96CD-15369C27E528Q42159559-9106D13C-644E-4001-8F6D-8434040F477DQ48316634-4FFA3E9E-4F78-4F31-9A47-B3A705CA49B6Q53224199-DF16BC0D-23C2-4004-A53E-7C2978E6C046Q53229811-26C329BA-B437-4C05-ADC1-77550FEEE66EQ57300288-9C6C6F24-C146-452A-A62A-976076741FD3
P2860
Calcium-channel blockers decrease clopidogrel-mediated platelet inhibition.
description
2009 nî lūn-bûn
@nan
2009 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Calcium-channel blockers decrease clopidogrel-mediated platelet inhibition.
@ast
Calcium-channel blockers decrease clopidogrel-mediated platelet inhibition.
@en
type
label
Calcium-channel blockers decrease clopidogrel-mediated platelet inhibition.
@ast
Calcium-channel blockers decrease clopidogrel-mediated platelet inhibition.
@en
prefLabel
Calcium-channel blockers decrease clopidogrel-mediated platelet inhibition.
@ast
Calcium-channel blockers decrease clopidogrel-mediated platelet inhibition.
@en
P2093
P356
P1433
P1476
Calcium-channel blockers decrease clopidogrel-mediated platelet inhibition
@en
P2093
Christoph W Kopp
Daniela Seidinger
Renate Koppensteiner
Sabine Steiner
Simon Panzer
P304
P356
10.1136/HRT.2009.171488
P407
P577
2009-08-16T00:00:00Z